Inventor · disambiguated record
Barrie Martin
Also filed as: MARTIN BARRIE · MARTIN BARRIE P · MARTIN BARRIE PHILLIP
11 granted patents·8 pending applications·32 citations·filing 2001–2024
87Inventor score
Top patents by PatentIndex Score
19 records- 0192US11753398B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2021·Granted Sep 12, 2023·2 cites·3 claims
- 0292US11130746B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2020·Granted Sep 28, 2021·3 cites·7 claims
- 0391US10696654B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2017·Granted Jun 30, 2020·10 cites·7 claims
- 0490US10611760B2Therapeutic compounds as inhibitors of the orexin-1 receptorC4X DISCOVERY LTD·Filed 2015·Granted Apr 7, 2020·9 cites·5 claims
- 0583US12441709B2Therapeutic compoundsINDIVIOR UK LTD·Filed 2023·Granted Oct 14, 2025·0 cites·13 claims
- 0678US12024509B2Therapeutic compounds as inhibitors of the orexin-1 receptorC4X DISCOVERY LTD·Filed 2020·Granted Jul 2, 2024·1 cites·23 claims
- 0772US12098148B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2019·Granted Sep 24, 2024·2 cites·32 claims
- 0865US7408065B2P2X7 receptor antagonists and their useASTRAZENECA AB·Filed 2004·Granted Aug 5, 2008·4 cites·8 claims
- 0965US2025084075A1Therapeutic compoundsC4X DISCOVERY LTD·Filed 2024·Application pending·0 cites
- 1062US6844348B22,3,4-cyclopentan-2,3,4-triol-1-yl compoundsASTRAZENECA AB·Filed 2001·Granted Jan 18, 2005·1 cites·15 claims
- 1156US7345047B2Substituted [1,2,3]triazolo[4,5-d]pyrimidinesASTRAZENECA AB·Filed 2004·Granted Mar 18, 2008·0 cites·16 claims
- 1253US2008207596A1Novel compounds 329MARTIN BARRIE·Filed 2007·Application pending·0 cites
- 1353US2010234355A1Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseasesMARTIN BARRIE·Filed 2007·Application pending·0 cites
- 1452US2023227427A1Il-17a modulatorsSANOFI SA·Filed 2021·Application pending·0 cites
- 1551US2023286943A1Il-17a modulatorsSANOFI SA·Filed 2021·Application pending·0 cites
- 1651US2023159511A1Tetrahydroisoquinoline compounds as nrf2 activatorsC4X DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1750US2009143354A1P2X7 Receptor Antagonists and Their UseEVANS RICHARD·Filed 2008·Application pending·0 cites
- 1845US8012979B2Compounds and their uses 707ASTRAZENECA AB·Filed 2008·Granted Sep 6, 2011·0 cites·13 claims
- 1938US2008153850A1Adamantyl Derivates as P2x7 Receptor AntagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →